5th TCR-based Therapies for Solid Tumors Summit

The 5th TCR-based Therapies for Solid Tumors Summit returns is back as the exclusive gathering where TCR pipelines take center stage. It serves as the premier platform for networking with biopharma industry leaders dedicated to expediting the clinical and commercial development of TCR-based therapeutics.

This summit serves as the epicenter for exploring these transformative advancements, poised to showcase the long-term efficacy of TCR therapies in the treatment of solid tumors, marking a monumental milestone in the field’s evolution.

This is your opportunity to accelerate next generation TCR engineering, enhance target identification, & improve solid tumor persistence to transform clinical & scalable development for patients in need. Join TScan Therapeutics, Marengo Therapeutics, T-Cypher Bio and more to gain invaluable insights into the future of TCR-based therapies.

Find out more here: https://ter.li/f8jhfw